-
公开(公告)号：US20240424260A1
公开(公告)日：2024-12-26
申请号：US18826388
申请日：2024-09-06
Applicant: BOSTON SCIENTIFIC SCIMED, INC.
Inventor： Kyle H. Srivastava , Vijay Koya , Jonathan B. Shute , Christopher Piere , Mark Kringle
Abstract: A navigation-assisting flexible elongate member, a navigation-assisting system, and a navigation-assisting method for use in navigating within a body to a treatment site. A navigation-assisting sensor, such as an optic fiber, an inductive sensor, a piezoelectric sensor, or a camera, is provided within the wall of the flexible elongate member, so as not to occupy space within a working channel defined by and through the flexible elongate member. When the distal end of the flexible elongate encounters an obstacle/another object (e.g., body tissue or a lumen wall), the navigation-assisting sensor generates a signal indicative of such encounter. Such signal is converted into information (such as by a control unit) usable to navigate the flexible elongate member away from the obstacle and on course to the treatment site.
-
公开(公告)号：US12109373B2
公开(公告)日：2024-10-08
申请号：US17473483
申请日：2021-09-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Kyle H. Srivastava , Vijay Koya , Jonathan B. Shute , Christopher Piere , Mark Kringle
CPC classification number: A61M25/0136 , A61M2025/0002 , A61M2205/0294 , A61M2205/3317 , A61M2205/3331
Abstract: A navigation-assisting flexible elongate member, a navigation-assisting system, and a navigation-assisting method for use in navigating within a body to a treatment site. A navigation-assisting sensor, such as an optic fiber, an inductive sensor, a piezoelectric sensor, or a camera, is provided within the wall of the flexible elongate member, so as not to occupy space within a working channel defined by and through the flexible elongate member. When the distal end of the flexible elongate encounters an obstacle/another object (e.g., body tissue or a lumen wall), the navigation-assisting sensor generates a signal indicative of such encounter. Such signal is converted into information (such as by a control unit) usable to navigate the flexible elongate member away from the obstacle and on course to the treatment site.
-
公开(公告)号：US11304633B2
公开(公告)日：2022-04-19
申请号：US16178872
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
IPC: A61N1/36 , A61N1/05 , A61B5/145 , A61B5/1486 , A61M5/172 , A61M5/142 , A61B5/00 , A61B5/1495
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
公开(公告)号：US20200215266A1
公开(公告)日：2020-07-09
申请号：US16732796
申请日：2020-01-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Keith R. Maile , Michael J. Kane , Jeffrey E. Stahmann , Elizabeth Mary Annoni
Abstract: A system may include an input device configured to receive a signal indicative of elevated glucose in a patient, and an electrical stimulator configured to electrically stimulate at least one skeletal muscle. The system may further include a controller operably connected to the electrical stimulator. The controller may be configured for delivering a glucose therapy in response to the signal by controlling the electrical stimulator. The system may be configured to deliver the therapy in combination with other glucose therapies, and the therapy may be titrated based on a sensed parameter or patient feedback.
-
公开(公告)号：US20190125227A1
公开(公告)日：2019-05-02
申请号：US16178872
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
Patent Agency Ranking
公开(公告)号：US20190125226A1
公开(公告)日：2019-05-02
申请号：US16178777
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include a controller operably connected to a diabetic therapy delivery system. The controller may be configured to: receive therapy inputs including a therapy input indicative of a glucose measure; determine a therapy input index using the at least one therapy input including the therapy input indicative of a glucose measure; map the determined therapy input index to a graded glucose control; and set the graded glucose control based on the mapped graded glucose control for the determined therapy input index, wherein the graded glucose control includes at least one of a neuromodulation target, a neuromodulation type, or at least one neuromodulation parameter value. The diabetic therapy delivery system may be configured to deliver the therapy for graded glucose control using the graded glucose control that was set based on the mapped graded glucose control.
-
公开(公告)号：US11883655B2
公开(公告)日：2024-01-30
申请号：US17182436
申请日：2021-02-23
Applicant: Boston Scientific Scimed, Inc.
Inventor： Kyle Harish Srivastava , Vijay Koya , Thomas Lee Williams , Miles Kealy , Nicholas Barron
CPC classification number: A61N1/36002 , A61N1/0509 , A61N1/08 , A61N1/36007 , A61N1/40
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system herein can include an electric field generating circuit configured to generate one or more electric fields, and control circuitry. The system can include one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient and one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient. The first and second stimulation leads can be configured to be implanted on or about a duodenum. The electric field generating circuit can generate electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.
-
公开(公告)号：US20220218241A1
公开(公告)日：2022-07-14
申请号：US17707343
申请日：2022-03-29
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
公开(公告)号：US20200069366A1
公开(公告)日：2020-03-05
申请号：US16553640
申请日：2019-08-28
Applicant: Boston Scientific Scimed, Inc.
Inventor： Bryan Allen Clark , Vijay Koya , Elizabeth M. Annoni , Hong Cao
Abstract: A system and method for denervation where a catheter includes a radially expandable member, the radially expandable member including an exterior surface, a plurality of electrodes on the exterior surface configured for delivery of energy during a denervation procedure in a vessel, and a chemical agent coating on the exterior surface, wherein the chemical agent inhibits or prevents nerve regeneration. The radially expandable member is configured to have a first unexpanded configuration and a second expanded configuration, and is configured to bring the exterior surface in contact with a wall of a vessel when it is in the expanded configuration.
-
公开(公告)号：US20220080154A1
公开(公告)日：2022-03-17
申请号：US17473483
申请日：2021-09-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Kyle H. Srivastava , Vijay Koya , Jonathan B. Shute , Christopher Piere , Mark Kringle
IPC: A61M25/01
Abstract: A navigation-assisting flexible elongate member, a navigation-assisting system, and a navigation-assisting method for use in navigating within a body to a treatment site. A navigation-assisting sensor, such as an optic fiber, an inductive sensor, a piezoelectric sensor, or a camera, is provided within the wall of the flexible elongate member, so as not to occupy space within a working channel defined by and through the flexible elongate member. When the distal end of the flexible elongate encounters an obstacle/another object (e.g., body tissue or a lumen wall), the navigation-assisting sensor generates a signal indicative of such encounter. Such signal is converted into information (such as by a control unit) usable to navigate the flexible elongate member away from the obstacle and on course to the treatment site.
-
-
-
-
-
-
-
-
-
Search Results
13
records
(took 0.017 seconds)
